Moneycontrol

You are Here : API facility to boost revenue by 5-10%: Nectar Lifesciences

Friday, 02:29

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the companys revenues by 5-10%.
AUG 17, 2017
03:04 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On